DIAGNOS AI Retina Analysis is being deployed across Canada’s Largest Specialist Care Provider in Diabetes & Endocrinology October 5, 2023 (Brossard, Québec, Canada) – DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a Canadian...
Canadian Eye Care Professionals and their Patients to Benefit from Innovative New Services, Increased Support, and Best-in-Class Products Oakville, ON: May 10th 2022 – As two world-class family companies with a passion for eye care, Laboratoires Théa and Labtician...
CAN Health Network and Quebec-Based DIAGNOS Announce Life-Changing Diabetic Retinopathy Screening Program Partnership Innovative diabetic retina screening service resulting in earlier intervention, better care, and savings to the Canadian healthcare system. March 15,...
DIAGNOS Announces its Exclusive Strategic Partnership Agreement with Labtician Ophthalmics, a Leader in Canadian and International Eyecare Markets to Address Growing Needs in the Monitoring of Diabetic and Hypertensive Patients Brossard, Quebec, Canada – February 24,...
